Elite Pharmaceuticals Inc /Nv/ financial data

Symbol
ELTP on OTC
Industry
Pharmaceutical Preparations
Location
165 Ludlow Avenue, Northvale, NJ
State of incorporation
NJ
Fiscal year end
March 31
Former names
ELITE PHARMACEUTICALS INC /DE/ (to 2/8/2012)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 280 % +9.51%
Quick Ratio 93.5 % -4.17%
Debt-to-equity 59.6 % +4.69%
Return On Equity -12.2 % -123%
Return On Assets -7.64 % -123%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.07B shares +5.36%
Common Stock, Shares, Outstanding 1.07B shares +5.36%
Entity Public Float 95.1M USD +135%
Common Stock, Value, Issued 1.07M USD +5.36%
Weighted Average Number of Shares Outstanding, Basic 1.07B shares +5.36%
Weighted Average Number of Shares Outstanding, Diluted 1.07B shares +4.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 71.2M USD +73.4%
Cost of Revenue 39.3M USD +86.8%
Research and Development Expense 7.25M USD -6.79%
General and Administrative Expense 8.19M USD +51.5%
Operating Income (Loss) 14.6M USD +186%
Nonoperating Income (Expense) -21.4M USD -388%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -6.77M USD -1044%
Income Tax Expense (Benefit) 232K USD +49.7%
Net Income (Loss) Attributable to Parent -6.39M USD -136%
Earnings Per Share, Basic 0 USD/shares -100%
Earnings Per Share, Diluted 0 USD/shares -100%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7.11M USD -9.27%
Accounts Receivable, after Allowance for Credit Loss, Current 21.4M USD +104%
Inventory, Net 14.2M USD -6.96%
Assets, Current 45.3M USD +30.4%
Deferred Income Tax Assets, Net 20.8M USD +7.26%
Property, Plant and Equipment, Net 10.2M USD +4.16%
Operating Lease, Right-of-Use Asset 2.09M USD +109907%
Assets 88.2M USD +24.7%
Accounts Payable, Current 1.98M USD -45%
Employee-related Liabilities, Current 206K USD
Accrued Liabilities, Current 5.7M USD -48.9%
Contract with Customer, Liability, Current 12.2K USD -8.33%
Liabilities, Current 12.9M USD -32.6%
Contract with Customer, Liability, Noncurrent 2.22K USD -85.7%
Operating Lease, Liability, Noncurrent 1.74M USD
Other Liabilities, Noncurrent 40.6K USD +6.17%
Liabilities 40.9M USD +59.7%
Retained Earnings (Accumulated Deficit) -127M USD -5.31%
Stockholders' Equity Attributable to Parent 47.3M USD +4.82%
Liabilities and Equity 88.2M USD +24.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 3.14M USD
Net Cash Provided by (Used in) Financing Activities -175K USD -104%
Net Cash Provided by (Used in) Investing Activities -1.66M USD
Common Stock, Shares Authorized 1.45B shares 0%
Common Stock, Shares, Issued 1.07B shares +5.36%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.31M USD +4.72%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 10M USD +10.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 223K USD +86.7%
Deferred Tax Assets, Valuation Allowance 2.04M USD
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.12 pure
Deferred Tax Assets, Gross 24.3M USD +7.46%
Operating Lease, Liability 2.16M USD +99926%
Depreciation 1.21M USD -5.46%
Payments to Acquire Property, Plant, and Equipment 779K USD
Lessee, Operating Lease, Liability, to be Paid 21.2K USD -98.3%
Property, Plant and Equipment, Gross 26.6M USD +6.36%
Operating Lease, Liability, Current 422K USD +19425%
Lessee, Operating Lease, Liability, to be Paid, Year Two 624K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 18.9K USD +27.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +66.7%
Deferred Income Tax Expense (Benefit) 18.2K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 498K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 637K USD
Deferred Tax Assets, Operating Loss Carryforwards 15.5M USD -11.8%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) -1.52M USD -109%
Preferred Stock, Shares Authorized 50 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 651K USD
Additional Paid in Capital 173M USD +5.16%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 322K USD -1.88%
Deferred Tax Assets, Net of Valuation Allowance 24.3M USD +1018%
Share-based Payment Arrangement, Expense 207K USD +141%
Interest Expense 589K USD -47.1%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%